Cargando…
Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries
Background: Maternal respiratory syncytial virus (RSV) vaccines that are likely to be implementable in low- and middle-income countries (LMICs) are in final stages of clinical trials. Data on the number of women presenting for antenatal care (ANC) per day and proportion attending within the proposed...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369009/ https://www.ncbi.nlm.nih.gov/pubmed/37502177 http://dx.doi.org/10.12688/wellcomeopenres.19161.1 |
_version_ | 1785077665115406336 |
---|---|
author | Nyiro, Joyce U. Nyawanda, Bryan O. Bukusi, Elizabeth Mureithi, Marianne W. Murunga, Nickson Nokes, D. James Bigogo, Godfrey Otieno, Nancy A. Opere, Victor A. Ouma, Alice Pecenka, Clint Munywoki, Patrick K. |
author_facet | Nyiro, Joyce U. Nyawanda, Bryan O. Bukusi, Elizabeth Mureithi, Marianne W. Murunga, Nickson Nokes, D. James Bigogo, Godfrey Otieno, Nancy A. Opere, Victor A. Ouma, Alice Pecenka, Clint Munywoki, Patrick K. |
author_sort | Nyiro, Joyce U. |
collection | PubMed |
description | Background: Maternal respiratory syncytial virus (RSV) vaccines that are likely to be implementable in low- and middle-income countries (LMICs) are in final stages of clinical trials. Data on the number of women presenting for antenatal care (ANC) per day and proportion attending within the proposed gestational window for vaccine delivery, is a prerequisite to guide development of vaccine vial size and inform vaccine uptake in this setting. Methods: We undertook administrative review and abstraction of ANC attendance records from 2019 registers of 24 selected health facilities, stratified by the level of care, from Kilifi, Siaya and Nairobi counties in Kenya. Additional data were obtained from Mother and Child Health (MCH) booklets of women in each of the Health and Demographic Surveillance System (HDSS) areas of Kilifi, Nairobi and Siaya. Data analysis involved descriptive summaries of the number (mean, median) and proportion of women attending ANC within the gestational window period of 28-32 weeks and 24-36 weeks. Results: A total of 62,153 ANC records were abstracted, 33,872 from Kilifi, 19,438 from Siaya and 8,943 from Nairobi Counties. The median (Interquartile range, IQR) number of women attending ANC per day at a gestational age window of 28-32 and 24-36 weeks, respectively, were: 4 (2-6) and 7 (4-12) in dispensaries, 5 (2-9) and 10 (4-19) in health centres and 6 (4-11) and 16 (10-26) in county referral hospitals. In the HDSS areas of Kilifi, Siaya and Nairobi, pregnant women attending at least one ANC visit, within a window of 28-32 weeks, were: 77% (360/470), 75% (590/791) and 67% (547/821), respectively. Conclusions: About 70% of pregnant women across three distinct geographical regions in Kenya, attend ANC within 28-32 weeks of gestation. A multidose vial size with about five doses per vial, approximates daily ANC attendance and would not incur possible wastage in similar settings. |
format | Online Article Text |
id | pubmed-10369009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-103690092023-07-27 Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries Nyiro, Joyce U. Nyawanda, Bryan O. Bukusi, Elizabeth Mureithi, Marianne W. Murunga, Nickson Nokes, D. James Bigogo, Godfrey Otieno, Nancy A. Opere, Victor A. Ouma, Alice Pecenka, Clint Munywoki, Patrick K. Wellcome Open Res Research Article Background: Maternal respiratory syncytial virus (RSV) vaccines that are likely to be implementable in low- and middle-income countries (LMICs) are in final stages of clinical trials. Data on the number of women presenting for antenatal care (ANC) per day and proportion attending within the proposed gestational window for vaccine delivery, is a prerequisite to guide development of vaccine vial size and inform vaccine uptake in this setting. Methods: We undertook administrative review and abstraction of ANC attendance records from 2019 registers of 24 selected health facilities, stratified by the level of care, from Kilifi, Siaya and Nairobi counties in Kenya. Additional data were obtained from Mother and Child Health (MCH) booklets of women in each of the Health and Demographic Surveillance System (HDSS) areas of Kilifi, Nairobi and Siaya. Data analysis involved descriptive summaries of the number (mean, median) and proportion of women attending ANC within the gestational window period of 28-32 weeks and 24-36 weeks. Results: A total of 62,153 ANC records were abstracted, 33,872 from Kilifi, 19,438 from Siaya and 8,943 from Nairobi Counties. The median (Interquartile range, IQR) number of women attending ANC per day at a gestational age window of 28-32 and 24-36 weeks, respectively, were: 4 (2-6) and 7 (4-12) in dispensaries, 5 (2-9) and 10 (4-19) in health centres and 6 (4-11) and 16 (10-26) in county referral hospitals. In the HDSS areas of Kilifi, Siaya and Nairobi, pregnant women attending at least one ANC visit, within a window of 28-32 weeks, were: 77% (360/470), 75% (590/791) and 67% (547/821), respectively. Conclusions: About 70% of pregnant women across three distinct geographical regions in Kenya, attend ANC within 28-32 weeks of gestation. A multidose vial size with about five doses per vial, approximates daily ANC attendance and would not incur possible wastage in similar settings. F1000 Research Limited 2023-04-03 /pmc/articles/PMC10369009/ /pubmed/37502177 http://dx.doi.org/10.12688/wellcomeopenres.19161.1 Text en Copyright: © 2023 Nyiro JU et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Nyiro, Joyce U. Nyawanda, Bryan O. Bukusi, Elizabeth Mureithi, Marianne W. Murunga, Nickson Nokes, D. James Bigogo, Godfrey Otieno, Nancy A. Opere, Victor A. Ouma, Alice Pecenka, Clint Munywoki, Patrick K. Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries |
title | Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries |
title_full | Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries |
title_fullStr | Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries |
title_full_unstemmed | Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries |
title_short | Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries |
title_sort | assessment of gestational age at antenatal care visits among kenyan women to inform delivery of a maternal respiratory syncytial virus (rsv) vaccine in low- and middle-income countries |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369009/ https://www.ncbi.nlm.nih.gov/pubmed/37502177 http://dx.doi.org/10.12688/wellcomeopenres.19161.1 |
work_keys_str_mv | AT nyirojoyceu assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT nyawandabryano assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT bukusielizabeth assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT mureithimariannew assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT murunganickson assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT nokesdjames assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT bigogogodfrey assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT otienonancya assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT operevictora assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT oumaalice assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT pecenkaclint assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries AT munywokipatrickk assessmentofgestationalageatantenatalcarevisitsamongkenyanwomentoinformdeliveryofamaternalrespiratorysyncytialvirusrsvvaccineinlowandmiddleincomecountries |